Literature DB >> 8969893

Effects of long term stimulation of ACTH and angiotensin II-secretions on the rat adrenal cortex.

F Mitani1, H Miyamoto, K Mukai, Y Ishimura.   

Abstract

In the rat adrenal cortex, aldosterone synthase cytochrome P450 (P450aldo), a mineralocorticoid synthesizing enzyme, localizes in the zona glomerulosa (zG), while cytochrome P45011 beta (P45011 beta), a glucocorticoid synthesizing enzyme, localizes in the zonae fasciculata-reticularis (zFR). In between zG and zF, a cell-layer which contains neither P450aldo nor P45011 beta is present, where replicating cells were abundant as judged by the incorporation of bromodeoxyuridine (BrdU) and/or by detecting PCNA in their nuclei. When plasma ACTH level of the rat was raised 3-fold for 2-3 weeks by the administration of metyrapone, a potent inhibitor of glucocorticoid formation, most of zG cells containing P450aldo disappeared, while zF cells with P45011 beta increased. Under the conditions, the cell-layer without P450aldo and P45011 beta became very thin, and replicating cells were mainly in the outermost portion of zF. When angiotensin II secretion was also stimulated for 2-3 weeks by feeding the rats on Na-deficient diet, the P450aldo-containing cells proliferated to form a thicker zG (7-8 cells-thick from 1-2), while the width of zF containing P45011 beta decreased slightly. Coincidently the cell-layer devoid of P450aldo and P45011 beta became thin, though slightly, and numbers of replicating cells significantly increased in and around the inner edge of the proliferated zG. When both ACTH and angiotensin II secretions were stimulated simultaneously, the cell-layer without P450aldo and P45011 beta almost disappeared and replicating cells were around the boundary of zG and zF. Based on these results we propose that the cell-layer between zG and zF devoid of P450aldo and P45011 beta is the stem cell layer of rat adrenal cortex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8969893     DOI: 10.1080/07435809609043728

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  8 in total

1.  Chronic cerebral hypoperfusion in male rats results in sustained HPA activation and hyperinsulinemia.

Authors:  Theresa A Lansdell; Anne M Dorrance
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-11-08       Impact factor: 4.310

Review 2.  Adrenal histopathology in primary aldosteronism: is it time for a change?

Authors:  Francesca Gioco; Teresa Maria Seccia; Elise P Gomez-Sanchez; Gian Paolo Rossi; Celso E Gomez-Sanchez
Journal:  Hypertension       Date:  2015-08-03       Impact factor: 10.190

Review 3.  Sonic hedgehog signaling during adrenal development.

Authors:  Ed Laufer; Dörthe Kesper; Andrea Vortkamp; Peter King
Journal:  Mol Cell Endocrinol       Date:  2011-10-13       Impact factor: 4.102

Review 4.  Functional Zonation of the Adult Mammalian Adrenal Cortex.

Authors:  Gavin P Vinson
Journal:  Front Neurosci       Date:  2016-06-15       Impact factor: 4.677

Review 5.  Aldosterone-Regulated Sodium Transport and Blood Pressure.

Authors:  Akaki Tsilosani; Chao Gao; Wenzheng Zhang
Journal:  Front Physiol       Date:  2022-02-07       Impact factor: 4.566

6.  Effects of ACTH, dexamethasone, and adrenalectomy on 11beta-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) gene expression in the rat central nervous system.

Authors:  Ping Ye; Christopher J Kenyon; Scott M Mackenzie; Katherine Nichol; Jonathan R Seckl; Robert Fraser; John M C Connell; Eleanor Davies
Journal:  J Endocrinol       Date:  2008-02       Impact factor: 4.286

Review 7.  Functional zonation of the rat adrenal cortex: the development and maintenance.

Authors:  Fumiko Mitani
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2014       Impact factor: 3.493

8.  The Herbicide Atrazine Potentiates Angiotensin II-Induced Aldosterone Synthesis and Release From Adrenal Cells.

Authors:  Arthur D Zimmerman; Laci Mackay; Robert J Kemppainen; Melaney A Jones; Casey C Read; Dean Schwartz; Chad D Foradori
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-14       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.